Shares of HEALTHYWAY INC (HKEX: 02587) experienced a notable intraday surge, climbing more than 10%. As of the latest update, the stock was up 3.86%, trading at HK$3.5 with a turnover of approximately HK$50.87 million.

Share Repurchase Activity

The company has maintained its share buyback momentum from the start of the year, conducting five separate repurchases in April 2026. These transactions involved a cumulative total of 718,000 shares at a cost of around HK$3.3 million.

Financial Performance Turnaround

In the 2025 fiscal year, HEALTHYWAY INC reported a significant financial improvement. Revenue reached 1.563 billion yuan, marking a year-on-year increase of 30.13%. The company achieved a net profit of 54.338 million yuan, successfully turning a previous loss into a profit.

AI Business Milestones

A key area of progress for the company in 2025 was its artificial intelligence initiatives. Its AI digital employee product generated over 32 million yuan in revenue in its first year of launch. Furthermore, the AI doctor assistant has been deployed in more than 20 medical institutions and was selected as a representative AI case in Fujian province. This progress signifies the company's successful transition from technology research and development to commercial application.

Future Strategic Focus

HEALTHYWAY INC has indicated that it plans to continue increasing resource investment in its AI digital employee platform. The company aims to build a high-quality base of end-user assets through the ongoing deployment process.